These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2294873)

  • 1. A nationwide survey of urinalysis practices of methadone maintenance clinics. Utilization of laboratory services.
    Saxon AJ; Calsyn DA; Haver VM; Erickson L
    Arch Pathol Lab Med; 1990 Jan; 114(1):94-100. PubMed ID: 2294873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol and other drugs: an assessment of testing and clinical practices in U.S. trauma centers.
    Soderstrom CA; Dailey JT; Kerns TJ
    J Trauma; 1994 Jan; 36(1):68-73. PubMed ID: 8295251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine screening practices in methadone maintenance clinics. A survey of how the results are used.
    Calsyn DA; Saxon AJ; Barndt DC
    J Nerv Ment Dis; 1991 Apr; 179(4):222-7. PubMed ID: 2007893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity.
    Rogers SC; Pruitt CW; Crouch DJ; Caravati EM
    Pediatr Emerg Care; 2010 Sep; 26(9):665-6. PubMed ID: 20838187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory support of drug abuse control programs: an overview.
    Decker WJ
    Clin Toxicol; 1977; 10(1):23-35. PubMed ID: 322933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting?
    Bennett GA; Davies E; Thomas P
    Drug Alcohol Depend; 2003 Dec; 72(3):265-9. PubMed ID: 14643943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1990 Sep; 55(172):36317-8. PubMed ID: 10170592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of reported drug use and urinalysis in the assessment of drug use.
    Jain R; Tripathi BM; Singh R
    Natl Med J India; 2001; 14(5):315-6. PubMed ID: 11767230
    [No Abstract]   [Full Text] [Related]  

  • 18. An overview of the use of urine, hair, sweat and saliva to detect drug use.
    Dolan K; Rouen D; Kimber J
    Drug Alcohol Rev; 2004 Jun; 23(2):213-7. PubMed ID: 15370028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation of drug use and urine screening patterns.
    Crosby RD; Carlson GA; Specker SM
    J Addict Dis; 2003; 22(3):89-98. PubMed ID: 14621347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underreporting of illicit drug use by patients at emergency departments as revealed by two-tiered urinalysis.
    Chen WJ; Fang CC; Shyu RS; Lin KC
    Addict Behav; 2006 Dec; 31(12):2304-8. PubMed ID: 16564643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.